The College’s Telehealth and Technology Task Force, chaired by Tania Elliott, MD, FACAAI, has been instrumental in assessing technology needs for allergy practices and driving our collaboration with the AMA’s Telehealth Immersion Program.
As part of our collaboration, the College co-hosted a webinar last winter, titled “A Clinical Case Study: Telehealth for Allergy, Asthma and Immunology,” featuring two members of the Task Force, Drs. Tania Elliott and Sofija Volertas. We also participated in the AMA’s national telehealth survey, which resulted in 2021 allergy/immunology telehealth survey results.
“Ninety-two percent of allergy/immunology respondents to the AMA’s recent telehealth survey use some form of telehealth in their practice,” said Dr. Elliott. “Telehealth is here to stay, and we hope to build on this framework to help allergy/immunology practices offer additional technology-based services, including remote patient monitoring, technologies that encourage healthy patient behaviors, e-visits and more.”
The Task Force is currently exploring feasibility of outcomes-based research in telehealth and technology related topics for allergy/immunology. Through our partnership with the AMA, we hope to be able to analyze and measure the value of telehealth for clinical use cases using a “return on health” framework. We are working together to identify case studies and outcome data for allergy/immunology and ultimately be able to create additional telehealth and technology resources for practicing allergists.